LONDON BROKER RATINGS: Berenberg raises Vodafone; Barclays cuts Hikma
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
| Price | 1,880.50p on 14-01-2026 at 19:25:08 |
|---|---|
| Change | 22.50p 1.21% |
| Buy | 1,872.00p |
| Sell | 1,871.00p |
| Last Trade: | Unknown 88,344.00 at 1,856.50p |
| Day's Volume: | 6,552,424 |
| Last Close: | 1,880.50p |
| Open: | 1,856.50p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,853.50p - 1,880.50p |
| 52wk Range: | 1,242.50p - 1,909.50p |
| Market Capitalisation: | £75.86b |
| VWAP: | 1,871.11447p |
| Shares in Issue: | 4.03b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 88,344 | 1,856.50p | OTC Trade |
19:08:49 - 14-Jan-26 |
| Unknown* | 88,344 | 1,856.50p | OTC Trade |
19:06:58 - 14-Jan-26 |
| Unknown* | 338,616 | 1,856.50p | OTC Trade |
18:38:45 - 14-Jan-26 |
| Unknown* | 338,616 | 1,856.50p | OTC Trade |
18:38:45 - 14-Jan-26 |
| Unknown* | 187,372 | 1,856.50p | OTC Trade |
18:29:24 - 14-Jan-26 |
| Unknown* | 187,372 | 1,856.50p | OTC Trade |
18:27:47 - 14-Jan-26 |
| Unknown* | 200,000 | 1,872.4773p | OTC Trade |
16:38:54 - 14-Jan-26 |
| Buy* | 81 | 1,880.50p | SI Trade |
16:35:20 - 14-Jan-26 |
| Buy* | 668 | 1,880.50p | SI Trade |
16:35:20 - 14-Jan-26 |
| Buy* | 404 | 1,880.50p | SI Trade |
16:35:20 - 14-Jan-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 7th Jan 2026 7:05 am | RNS | EC approval of Shingrix PFS |
| 7th Jan 2026 7:00 am | RNS | Positive phase 3 data for GSK's bepirovirsen |
| 6th Jan 2026 7:00 am | RNS | Exdensur approved in Japan |
| 5th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 5th Jan 2026 3:00 pm | RNS | Total Voting Rights |
| 5th Jan 2026 7:00 am | RNS | Nucala for adults with COPD approved in China |
| 22nd Dec 2025 3:30 pm | RNS | Director/PDMR Shareholding |
| 22nd Dec 2025 3:30 pm | RNS | Director/PDMR Shareholding |
| 22nd Dec 2025 7:00 am | RNS | GSK to lower drug prices and expand access in US |